glp 1 ra black box warning GLP-1 Side Effects and Cancer Risk: What Current Research Really Shows Trulicity Lawsuit - July 2026

The decision to stop tirzepatide should always involve shared decision-making with your healthcare provider, considering individual circumstances, treatment goals, and the availability of alternative management strategies

Constipation is more common at higher doses

GLP-1R agonists may exert antidepressant effects by modulating inflammatory processes in the brain Chronic inflammatory processes in the brain associated with excessive activation of microglia and increased production of pro-inflammatory cytokines are one of the key factors leading to the development of depressive symptoms, as patients suffering from this mental illness are very often characterized by elevated levels of tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), interleukin-1 beta (IL-1), C-reactive protein (CRP), and interferon-gamma (IFN-) in the cerebrospinal fluid and the blood [59,60,61]

For uninsured patients, every alternative pathway to accessible treatment is explored